发明名称 |
HELICOBACTER PYLORI ANTIGENS: FUSION OF FAY 31 AND HPA 44 |
摘要 |
The present invention concerns a pharmaceutical product, e.g. a vaccine composition or vaccine kit, which comprises Fay31 and HOP38 polypeptides. The invention also concerns a fusion polypeptide comprising both Fay31 and HOP38 amino acid sequences, as well as a nucleic acid encoding such a fusion polypeptide. In addition, the invention concerns a pharmaceutical product comprising separate nucleotide sequences respectively encoding Fay31 and HOP38 polypeptides, Fay31 together with HOP38 provides a synergistic combination that can be used to treat and/or reduce the risk of <i>Helicobacter pylori</i> infection in a mammal.
|
申请公布号 |
WO0183532(A1) |
申请公布日期 |
2001.11.08 |
申请号 |
WO2001SE00871 |
申请日期 |
2001.04.24 |
申请人 |
ASTRAZENECA AB;DOIG, PETER;PAPPO, JACQUES |
发明人 |
DOIG, PETER;PAPPO, JACQUES |
分类号 |
A61K38/00;A61K39/00;A61K48/00;C07K14/205;(IPC1-7):C07K14/205;A61K39/106 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|